BACKGROUND: There is evidence linking oral propionate to a reduction in food intake, which could confer functional food properties in the fight against obesity. However, propionate is typically volatile with a pungent smell and taste and so incorporating into foods naturally, at levels acceptable to the consumer is a novel approach. SUBJECTS/METHODS: Twenty healthy, young, normal weight unrestrained eaters underwent an acute feeding study using a palatable sourdough and an identical control bread of a similar palatability, in a randomized cross-over balanced design for the assessment of appetite and energy intake. RESULTS: No difference in energy intake of an ad libitum test meal, 180 min after the bread-based breakfast or in energy and macronutrient intake over the entire 24 h period was found between breads. Visual analogue scale ratings for appetite were not influenced by bread type, except the desire to eat something sweet. Elevated plasma insulin concentrations were observed following the propionate-rich sourdough breakfast (P ¼ 0.033 no effects of treatment on postprandial glycaemia were found. CONCLUSIONS: These findings suggest propionate-rich sourdough bread does not influence appetite and food intake unlike larger doses of the food preservative N-propionate. Keywords: short-chain fatty acid; satiety; appetite; cephalic; palatability
INTRODUCTION
With the prevalence of obesity and consequent co-morbidities such as type 2 diabetes rising rapidly and projected to continue rising, 1 the need for strategies to limit food intake and to regulate metabolic profiles are becoming increasingly urgent. Bread makes a considerable contribution to energy intake (EI) in Western populations, with white bread being consumed by 79% of adults in the most recent UK National Diet and Nutrition Survey. 2 The modification of bread to promote satiety-enhancing properties and improve glycaemia therefore poses a pertinent functional food target.
There is a particular interest in the metabolic action of the shortchain fatty acid (SCFA), propionate. 3 Although it is considered that food delivery has limited effects on propionate levels in the circulation, 4 propionate supplied as sodium (Na) propionate baked into bread significantly increases subsequent satiety 5, 6 and reduced postprandial glycaemia 5 --7 and insulinaemia. 5, 6, 8 Possible mechanisms for observed effects on satiety, glycaemia and insulinaemia include delayed gastric emptying. 5, 8 The recently discovered short-chain fatty acid-activated G-coupled protein receptors, FFA2 (free fatty acid receptor 2) and FFA3 (free fatty acid receptor 3), may be implicated in mediating the physiological actions of propionate, 9 --15 with propionate being the most potent ligand for FFA3. 12 FFA3 and FFA2 are both expressed in adipocytes, and in vivo, short-chain fatty acid administration has been associated with elevated plasma leptin concentrations 16 and reduced plasma nonesterified fatty acid (NEFA) concentrations. 9 Although Na propionate is often added during the baking process as a preservative (E280) due to anti-bacterial and anti-fungal properties, there is an increasing concern by consumers about the overuse of food additives. 17 In addition, Na propionate has been linked to nausea 18 with Na propionateadulterated bread having a lower acceptability score to consumers due to taste. 6 Therefore, it is conceivable that propionate test products used previously triggered differing pre-ingestive responses compared with control due to their smell and unpleasant taste, resulting in the observed metabolic and appetite effects. 19 Sourdough-leavened breads are deemed to be 'traditional' products by the consumer but importantly may be a way of increasing levels of organic acids naturally present within food. There have been positive finding from conventional sourdough cultures favouring the production of lactic acid, 5, 6, 20, 21 however many of the mechanisms previously mentioned may be specific for propionic acid.
A starter culture (Domani) containing microflora favouring propionate production has been developed, resulting in a sourdough bread naturally rich in propionate, offering promise as a functional food product. The present study therefore aimed to investigate the acute effects of including this propionate-rich sourdough bread (SOUR), as a component of one meal, on appetite visual analogue scale (VAS) ratings, prospective food intake at a subsequent meal, 24 h intake and metabolic response compared with an identical control bread (made with yeast) of equal palatability.
METHODS
Prior to engaging in an appetite study, the hedonic properties of the test breads were first assessed using British Standard Guidelines 22 --26 to ensure the SOUR bread was acceptable and matched to the nonsourdough control bread product. The effects of the propionate-rich SOUR bread on appetite and the metabolic response were then investigated in an acute feeding study. Both studies were approved by the University of Surrey Ethics Committee and were conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All participants gave written informed consent prior to inclusion.
Sensory evaluation of test products Participants. Using a sensory evaluation panel of 14 healthy participants (4 male, 10 female) aged between 25 and 45 years (mean age 29.1±6.1 years). Restrained eating was assessed using the DEBQ (Dutch Eating Behaviour Questionnaire) 27 and those with a DEBQ restraint score X3.5 were excluded. Those who were not weight stable for the last 3 months, were on a weight-reducing diet, were smokers or had a high habitual alcohol intake were also excluded.
Bread test products for sensory evaluation. The propionate-rich SOUR bread was made using a starter culture, Domani, containing microflora, mainly propionibacteria, favouring propionate production. The Domani starter culture was used at levels of 1%, 2% and 3%, with the resultant SOUR bread containing increasing quantities of propionate (1.7 mmol, 3.4 mmol and 4.8 mmol per 100 g bread), respectively (assessed using gas chromotaogrpahy). During the baking process, it was found that levels above 3% had deleterious effects on the bread quality. Control bread using yeast, was made to a similar recipe with the same refined flour used in the baking of both breads. The 3% Domani SOUR bread used for the clinical study contained 4.8 mmol per 100 g bread (2.3 mg per g propionic acid and 2.98 mg per g calcium propionate).
Sensory evaluation protocol.
Six different tests were included in the sensory evaluation questionnaire (detailed in Table 1 ).
No differences in preference for the 3% Domani SOUR and control breads or in correctly identifying the odd one out from a choice of three samples (odd one out plus two identical samples) were found between treatments. Rank and acceptability scores for the 1, 2 and 3% Domani SOUR and control bread also did not differ significantly between bread types, and ratings for both aftertaste and the level of acidic taste did not differ between the control and 3% Domani SOUR bread.
Study 2: intervention study Participants. A total of 20 healthy participants (9 male, 11 female) aged between 18 and 35 years were recruited from the local population by poster advertisement (Table 2) . Eligibility criteria were: BMI between 19 and 27 kg/m 2 , fasting blood glucose o6.0 mmol/l, weight stable for at least 3 months, not following a weight-reducing diet, DEBQ restraint score o3.5, absence of gastrointestinal, endocrine or cardiovascular disorders, no history of depression, eating disorders or substance abuse, not pregnant or lactating, not taking regular medication (except birth control medication), non-smoker and reported habitual alcohol intake p20 units per week.
Protocol. Acute postprandial effects on plasma metabolites, subjective appetite sensations and EI in response to a mixed breakfast made using either the propionate-rich SOUR or the identical control bread, were investigated in this single-blind, randomized-controlled crossover study. Subjective appetite sensations were assessed using 100 mm VAS for fullness, hunger, prospective food consumption and desire to eat sweet/savoury/salty/fatty as previously described. 28, 29 Participants attended study mornings at the Clinical Investigation unit on two occasions separated by at least 1 week. To control for the effects of hormonal variations throughout the menstrual cycle, 30 female participants not using birth control medication attended at approximately the same point in the follicular phase of their menstrual cycle for each study morning. Participants were required to stay in the Clinical Investigation unit for the entire study duration and water was provided ad libitum.
During the 24 h preceding the study morning, participants were required to complete 24-h diet diaries and to refrain from unaccustomed exercise and alcohol consumption. A standard, commercially prepared low-fat/low-fibre evening meal (pasta dish and a dessert; 2659 kJ, 68.8 g carbohydrate, 23.6 g fat and 3.5 g total dietary fibre) was provided to be consumed for the evening meal on the night before the test day (to reduce baseline plasma levels of short-chain fatty acid).
Participants arrived at the Clinical Investigation unit at approximately 0830 hrs following an overnight fast. Upon arrival, anthropometric measurements were taken and an intravenous cannula was inserted into an antecubital vein. Two fasting blood samples were taken 30 and 5 min before breakfast, and two initial VAS to subjectively assess appetite were completed following each blood sample.
Participants were provided with the mixed breakfast made using SOUR or control bread (described below) at time ¼ 0 min, which they were asked to consume within 15 min. Following breakfast, participants completed VAS regarding the palatability and pleasantness of the breakfast. Blood samples were collected at 15, 30, 45, 60, 90, 120 and 180 min postprandially and VAS to assess appetite were completed after blood samples at 30, 60, 90, 120 and 180 min postprandially.
The cannula was removed 180 min following breakfast, and participants were seated in confined individual booths free from distractions and served an ad libitum test meal (described below) in a quantity exceeding usual portion sizes as previously used by our group. 31 They were instructed to eat freely until they were 'comfortably full'. Participants were asked to complete a diet diary for the remainder of the day that, in combination Blood sample processing and analysis. Venous blood was collected into sodium oxalate tubes for glucose analysis and into potassium EDTA tubes for insulin and lipid analysis. Samples were centrifuged at 1750 g for 10 min and plasma aliquots were stored at À20 1C. Samples were batch analysed at the end of the study to minimise inter-assay variability. Plasma glucose, triglyceride, NEFA and total and HDL cholesterol concentrations were measured by an enzymatic calorimetric method using commercially available kits for the ILAB 650 analyser (Instrumentation Laboratory, Milan, Italy), with an inter-assay variation of o2%. Plasma insulin concentrations were quantified by radioimmunoassay using a commercially available kit (Millipore, St Charles, MO, USA) and were analysed in duplicate. The kit had a sensitivity of 2 mU/ml and an inter-and intra-assay coefficient of variation of o10%.
Calculations and statistical analysis. The primary outcome for the study was EI at the ad libitum test meal provided 180 min postprandially. Sample size was based on data from a previous investigation carried out by our group. 31 In this study, the standard deviation of difference in EI between two treatments was 293 kJ and the error of difference was 247 kJ. From this it was estimated that 17 participants are required to detect a treatment difference at a two-sided significance level of 5% (P ¼ 0.05) with a power of 0.9. We aimed to recruit 20 participants in order to account for potential drop-outs. Previous studies investigating the role of SOUR bread have used between 11 and 16 subjects. 5, 6, 20, 21 All statistical analyses were conducted using SPSS for Windows 16.0 (SPSS Inc, Chicago, IL, USA). Data was tested for normality using the Kolmogorov --Smirnov test. Postprandial time-course data was assessed by two-way repeated measures ANOVA with treatment and time as withinsubject factors. Differences between groups were assessed by paired samples t-test if normally distributed, and by Wilcoxon signed-ranks test if not normally distributed. The minimal model method 32 was used to assess postprandial insulin sensitivity. Area under the curve (AUC) was calculated for postprandial plasma metabolites and subjective appetite ratings using the trapezoidal rule. Data in text are presented as mean±s.d. unless stated otherwise.
RESULTS

Test breakfast palatability
There was no difference in rated breakfast palatability (75±14 mm vs 69 ± 21 mm), pleasantness of taste (70 ± 17 mm vs 67 ± 17 mm) or acidity (33 ± 22 mm vs 35 ± 21 mm) between control and SOUR treatments, respectively.
Postprandial intake at ad libitum test meal and for the entire 24 h period The mean EI of the ad libitum pasta test lunch provided 180 min postprandially did not differ between treatments following consumption of control and SOUR breakfast meals (Table 4a) . The 24 h mean EI for the entire study day was 543 ± 2070 kJ lower with SOUR treatment than with control. However, this difference was non significant and no significant differences in macronutrient intake were found between treatments (Table 4b ).
Effects on VAS appetite ratings No treatment or treatment Â time effects were found for postprandial appetite ratings over 180 min for fullness (Figure 1a) , hunger, prospective consumption or desire to eat savoury/fatty/ salty following control and SOUR and the area under the curve did not differ between treatments. Postprandial ratings for the desire to eat something sweet were significantly lower (P ¼ 0.024) following SOUR than following control (Figure 1b) .
Postprandial metabolites
The mean plasma insulin response following ingestion of SOUR remained elevated above control from 45 to 90 min postprandially (Figure 2a) . A treatment Â time effect with a trend approaching significance (P ¼ 0.061) was found for the entire 180 min, which was significant for the first 60 min (P ¼ 0.033). The overall treatment effect was non significant and the area under the curve did not differ between treatments. The postprandial NEFA response was significantly influenced by treatment (P ¼ 0.025, Figure 2c ), with the area under the curve following SOUR being significantly higher than following control (P ¼ 0.007, data not shown). Neither the postprandial glycaemic (Figure 2b ) nor triglyceride (data not shown) responses were significantly influenced by treatment nor was there a treatment Â time effect for either metabolite.
Postprandial insulin sensitivity The estimated mean postprandial oral insulin sensitivity was lower following SOUR than control, being 1.8. ± 1.0 dl/kg min and 2.2±1.2 Â 10 À3 dl/kg min per mU ml, respectively. However, the difference between these values were non significant. Oral propionate and food intake J Darzi et al
DISCUSSION
The main findings from the present investigation were that the provision of 6 mmol oral propionate in a palatable form, which would be acceptable to a consumer within a mixed meal (a) did not significantly influence appetite, with no effects on ad libitum EI 180 min postprandially, on 24 h intake or on subjective appetite ratings except the desire to eat sweet, (b) may enhance insulin secretion and (c) did not significantly influence postprandial glycaemia or insulin sensitivity. To our knowledge, this is the first study in which propionate has been delivered as part of a meal in a palatable form using a test product that would be considered a 'real' unmodified food that can be purchased and incorporated into the diet. Our findings are in contrast to previous studies that found ingestion of Na propionate baked into bread acutely reduced postprandial glycaemia 5 --7 and insulinaemia 5, 6, 8 and significantly increased subjective satiety ratings, 5, 6 relative to control. In previous studies 5 --8 the unpleasant taste of Na propionate was not controlled for and was therefore a serious cofounder. The sensory properties of food significantly influence post-metabolic handling with vagal stimulation initiating insulin release (cephalic phase insulin release), 33 --36 gastric secretions 37, 38 and intestinal motility 39, 40 amongst others. Palatability of the food has been thought to impact on satiation rather than satiety, 41 as measured here however, although a meal of reduced palatability causes reduced ad libitum intake of that food (increased satiation), subjects do not compensate and eat more at the next meal as would be expected based on EI alone, as such overall food intake is lower with a reduced palatability. Indeed, Yeomans found a strong linear relationship between the change in rated palatability and differences in food intake in response to a food stimulus when data was pooled from studies in which palatability was manipulated. 42 For example, intake and taste ratings of an ice cream adulterated with a bitter taste were significantly lower than unadulterated ice cream. 43 When product palatability was modified by the addition of a bitter taste (quinine), subsequent gastric emptying was significantly delayed compared with the same product without added quinine, presumably due to a direct effect on gastrointestinal motility. 44 Based on this evidence, the reduced postprandial insulinaemic and glycaemic responses 5 --8 following oral propionate ingestion in previous studies may be attributed to the unpleasant taste of the Na propionate breads. Acceptability ratings for the Na propionate breads used in previous studies were significantly lower than control. 6 By contrast, in the present study, prior sensory evaluation determined participants found that SOUR was no less preferable than the control.
It should be considered that the SOUR bread in the present study delivered less propionate (6.0 mmol) than in the previous studies, 5 --8 which may explain the lack of effect in the present study. However, when added at higher doses, propionate makes food unpalatable and changes product quality and is therefore of limited use nutritionally or commercially. The present study found that ingestion of a mixed meal made using the palatable SOUR bread may enhance postprandial insulinaemia. To our knowledge, this is the first time that such an observation has been made following oral administration of propionate in humans. 45 reported rectal administration of a propionate solution significantly increased blood glucose concentrations whereas acetate and saline solutions did not, which they suggested originated from an hepatic gluconeogenic effect of propionate in humans. Propionate is well documented to have gluconeogenic effects in ruminants, and is the primary glucose source via hepatic metabolism. 46 Based on this, in the present study we postulate that propionate was absorbed from the gastrointestinal tract and traversed to the liver via the portal vein to be metabolised to glucose, thus enhancing insulin secretion. Why did this not occur in previous studies using Na propionate bread? In previous studies, it is possible that whereas gluconeogenesis may have occurred, the unpleaseant hedonic properties delayed gastric emptying, which of course is an evolutionary effect to prevent poisoning, so masking the other metabolic effects.
Postprandial plasma NEFA concentrations were also significantly influenced by treatment (P ¼ 0.025, suggestive that SOUR may have suppressed NEFA concentrations to a greater degree than did control. Plasma triglyceride levels were not significantly influenced. To our knowledge, this is the first study to investigate postprandial effects of oral propionate ingestion on plasma lipid responses.
As such, there is no evidence that oral propionate provided in a 'natural' form from bacterial fermentation, in bread products, which would be palatable and acceptable to the consumer has an effect on indices of appetite of food intake.
We propose that the results from the previous studies 5 --8 may have resulted from hedonic properties of the test bread delaying gastric emptying rather than post-absorptive physiological effects of propionate. Overall, our results do not support the promotion of propionate-rich SOUR bread as a functional food product 47 as we do not consider it likely to reduce disease risk or confer additional health benefits.
